You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Breast-adjuvant

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide combined with fulvestrant)

Not yet recruiting
  • Hormone Receptor-positive Advanced Breast Cancer
  • chidamide combined with fulvestrant
  • (no location specified)
Mar 28, 2023

Breast Cancer Trial in Shanghai (Pertuzumab)

Not yet recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Shanghai Jiaotong University School of Medicine affiliated Ruiji
Jun 4, 2023

LYNPARZA Breast Cancer in Adjuvant Setting Japan Post-Marketing

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jan 9, 2023

    TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • (no location specified)
    May 8, 2023

    Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:

    Recruiting
    • Pleomorphic Lobular Breast Carcinoma in Situ
    • Breast Florid Lobular Carcinoma in Situ
    • Surgical wide local excision
    • +4 more
    • Padova, Italy
      Istituto Oncologico Veneto IRCCS
    Nov 14, 2023

    Breast Cancer Trial in Amiens, Caen, Rouen (self questionnaires)

    Completed
    • Breast Cancer
    • self questionnaires
    • Amiens, France
    • +2 more
    Dec 22, 2022

    Breast Cancer Trial in Rozzano (external beams radiotherapy, brachytherapy)

    Recruiting
    • Breast Cancer
    • external beams radiotherapy
    • brachytherapy
    • Rozzano, Milano, Italy
      IRCCS Istituto Clinico Humanitas
    Jan 13, 2023

    Breast Cancer, Osteopenia Trial in Valencia (bone densitometry)

    Recruiting
    • Breast Cancer
    • Osteopenia
    • bone densitometry
    • Valencia, Spain
      Hospital Clínico Universitario de Valencia
    Mar 9, 2023

    Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)

    Not yet recruiting
    • Breast Cancer Female
    • Triple Negative Breast Cancer
    • quercetin, EGCG, metformin , zinc
    • (no location specified)
    Dec 23, 2022

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

    Not yet recruiting
    • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    • (no location specified)
    Sep 26, 2023

    Therapeutic Mammoplasty on the Start of Adjuvant Chemotherapy

    Completed
    • Effect of Therapeutic Mammoplasty on Adjuvant Chemotherapy
    • therapeutic mammoplasty
    • (no location specified)
    Jun 16, 2023

    Breast Cancer, Axillary Nodal Disease, Female Breast Cancer Trial (Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant

    Not yet recruiting
    • Breast Cancer
    • +5 more
    • Breast Surgery (BCS or mastectomy) with TAD/SNB
    • Adjuvant Radiation Therapy
    • (no location specified)
    Oct 24, 2023

    Profiling to Help Define Need for Neo-Adjuvant Chemotherapy in

    Recruiting
    • Breast Cancer
    • GEP
    • Jette, Brussel, Belgium
      Universitair Ziekenhuis Brussel
    Dec 16, 2022

    Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

    Not yet recruiting
    • Breast Cancer, Early Breast Cancer
    • (no location specified)
    Jul 11, 2023

    Breast Cancer Trial in Istanbul (MYOVOLT (MyovoltTM, Myovolt Limited, Christchurch, New Zealand ) wearable vibration therapy

    Recruiting
    • Breast Cancer
    • MYOVOLT (MyovoltTM, Myovolt Limited, Christchurch, New Zealand ) wearable vibration therapy device
    • Home based exercise
    • Istanbul, Turkey
      Professor Cemil Taşcıoğlu Training and Research Hospital
    Jan 10, 2023

    Breast Cancer Trial in Shanghai (The RJBC-APP, Routine post-surgical follow-up)

    Not yet recruiting
    • Breast Cancer
    • The RJBC-APP
    • Routine post-surgical follow-up
    • Shanghai, Please Select, China
      Xiaosong Chen
    Jun 26, 2023

    Breast Cancer Female Trial in São Paulo (adjuvant ultra-hypofractionated radiotherapy)

    Completed
    • Breast Cancer Female
    • adjuvant ultra-hypofractionated radiotherapy
    • São Paulo, Brazil
      Instituto de Pesquisa Prevent Senior
    Apr 30, 2023

    Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

    Not yet recruiting
    • Triple-negative Breast Cancer
    • Pembrolizumab 25 mg/ml
    • Paclitaxel injection
    • (no location specified)
    Oct 11, 2023

    Breast Cancer Female Trial in Bani Suwayf (MetFORMIN 500 Mg Oral Tablet, Chemotherapy)

    Completed
    • Breast Cancer Female
    • Banī Suwayf, Egypt
      Marian S. Boshra
    May 2, 2023

    Concurrent Paclitaxel and Radiotherapy After Adjuvant

    Not yet recruiting
    • Breast Cancer
    • Concurrent chemoradiation
    • (no location specified)
    Oct 16, 2022

    Early-stage HER2-positive Breast Cancer, Treated With Neratinib

    Recruiting
    • Breast Cancer
    • +2 more
      • Bouge, Belgium
        Clinique Saint-Luc Bouge
      Oct 25, 2022

      Recurrence Score on Adjuvant Treatment Decisions in Breast

      Recruiting
      • Breast Cancer Female
        • Tübingen, BW, Germany
          Department for Women's Health
        Nov 4, 2022

        Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)

        Recruiting
        • Breast Cancer
        • Capecitabine+endocrine therapy
        • Placebo+endocrine therapy
        • Zhengzhou, Henan, China
          Henan cancer hospital
        Nov 19, 2022

        Albumin Binding Paclitaxel Compared With Common Paclitaxel in

        Recruiting
        • Breast Cancer
        • Jinan, Shandong, China
          The First Affiliated Hospital of Shandong First Medical Universi
        Nov 24, 2022

        Breast Cancer Trial in Boston, Danvers (Ribociclib, Endocrine therapy)

        Recruiting
        • Breast Cancer
        • Boston, Massachusetts
        • +2 more
        Jan 6, 2023